Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease

Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C (1997)
Proc. Natl. Acad. Sci. USA 94(6): 2642-2647.

Download
No fulltext has been uploaded. References only!
Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ;
Publishing Year
ISSN
PUB-ID

Cite this

Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA. 1997;94(6):2642-2647.
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., & Kaltschmidt, C. (1997). Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA, 94(6), 2642-2647.
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., and Kaltschmidt, C. (1997). Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 2642-2647.
Kaltschmidt, B., et al., 1997. Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA, 94(6), p 2642-2647.
B. Kaltschmidt, et al., “Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease”, Proc. Natl. Acad. Sci. USA, vol. 94, 1997, pp. 2642-2647.
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P.A., Kaltschmidt, C.: Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94, 2642-2647 (1997).
Kaltschmidt, Barbara, Uherek, M., Volk, B., Baeuerle, P.A., and Kaltschmidt, Christian. “Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease”. Proc. Natl. Acad. Sci. USA 94.6 (1997): 2642-2647.
This data publication is cited in the following publications:
This publication cites the following data publications:

291 Citations in Europe PMC

Data provided by Europe PubMed Central.

Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi.
Shijo M, Honda H, Suzuki SO, Hamasaki H, Hokama M, Abolhassani N, Nakabeppu Y, Ninomiya T, Kitazono T, Iwaki T., Brain Pathol. 28(1), 2018
PMID: 27997051
Epigenetic Regulatory Mechanisms Induced by Resveratrol.
Fernandes GFS, Silva GDB, Pavan AR, Chiba DE, Chin CM, Dos Santos JL., Nutrients 9(11), 2017
PMID: 29104258
Network-Driven Proteogenomics Unveils an Aging-Related Imbalance in the Olfactory IκBα-NFκB p65 Complex Functionality in Tg2576 Alzheimer's Disease Mouse Model.
Palomino-Alonso M, Lachen-Montes M, Gonzalez-Morales A, Ausin K, Perez-Mediavilla A, Fernandez-Irigoyen J, Santamaria E., Int J Mol Sci 18(11), 2017
PMID: 29077059
Loss of NLRX1 Exacerbates Neural Tissue Damage and NF-κB Signaling following Brain Injury.
Theus MH, Brickler T, Meza AL, Coutermarsh-Ott S, Hazy A, Gris D, Allen IC., J. Immunol. 199(10), 2017
PMID: 28993512
Regulation of Survival Motor Neuron Protein by the Nuclear Factor-Kappa B Pathway in Mouse Spinal Cord Motoneurons.
Arumugam S, Mincheva-Tasheva S, Periyakaruppiah A, de la Fuente S, Soler RM, Garcera A., Mol. Neurobiol. (), 2017
PMID: 28808928
Brain region- and sex-specific alterations in mitochondrial function and NF-κB signaling in the TgCRND8 mouse model of Alzheimer's disease.
Djordjevic J, Thomson E, Chowdhury SR, Snow WM, Perez C, Wong TP, Fernyhough P, Albensi BC., Neuroscience 361(), 2017
PMID: 28802916
Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.
Nho K, Kim S, Horgusluoglu E, Risacher SL, Shen L, Kim D, Lee S, Foroud T, Shaw LM, Trojanowski JQ, Aisen PS, Petersen RC, Jack CR Jr, Weiner MW, Green RC, Toga AW, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI)., BMC Med Genomics 10(Suppl 1), 2017
PMID: 28589856
The DNA Damage Response in Neurons: Die by Apoptosis or Survive in a Senescence-Like State?
Fielder E, von Zglinicki T, Jurk D., J. Alzheimers Dis. 60(s1), 2017
PMID: 28436392
Inhibition of the neuronal NFκB pathway attenuates bortezomib-induced neuropathy in a mouse model.
Ale A, Bruna J, Calls A, Karamita M, Haralambous S, Probert L, Navarro X, Udina E., Neurotoxicology 55(), 2016
PMID: 27211850
PPARδ agonist GW0742 ameliorates Aβ1-42-induced hippocampal neurotoxicity in mice.
An YQ, Zhang CT, Du Y, Zhang M, Tang SS, Hu M, Long Y, Sun HB, Hong H., Metab Brain Dis 31(3), 2016
PMID: 26864581
Anti-inflammatory effect of jeongshintang through suppression of p38 activation in human astrocytoma, U373MG cells.
Kim SJ, Jeong HJ, Kim BK, Kim NH, Kim JS, Choi KS, Lee HJ, Kang ST, Shin SS, Kim WI, Eom HS, Lee KM, Um JY, Hong SH, Kim HM., Exp. Mol. Pathol. 81(1), 2006
PMID: 16698013
Mutational study of the nuclear factor kappa B inducing kinase gene in patients with progressive supranuclear palsy.
Campdelacreu J, Ezquerra M, Munoz E, Oliva R, Tolosa E., Neurosci. Lett. 340(2), 2003
PMID: 12668260
Alzheimer's disease and brain development: common molecular pathways.
Jordan-Sciutto K, Bowser R., Front. Biosci. 3(), 1998
PMID: 9422711

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 9122249
PubMed | Europe PMC

Search this title in

Google Scholar